Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2008-09-26
- Lead Sponsor
- Metronome Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT00641160
- Locations
- 🇺🇸
Texas Oncology PA; Sammons Cancer Center, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath